Who Paid My Doc
M14-234
ClinicalTrials.gov NCT02819635
Research payments
$5,272,228
Through program year 2020, $5,272,228 in research payments was reported against M14-234, across 1,329 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT02819635
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $2,382,700 | 772 |
| 2019 | Research | $2,889,527 | 557 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Philip Ginsburg Hamden, CT Named on 77 payments
- Suzy Kim Greenville, SC Named on 34 payments
- Michael Georgetson Sayre, PA Named on 32 payments
- Henry Levine Orlando, FL Named on 32 payments
- Ronald Fogel Chesterfield, MI Named on 28 payments
- Karen Simon Oxnard, CA Named on 27 payments
- John Hong Fallbrook, CA Named on 27 payments
- Paul Hellstern Crystal River, FL Named on 27 payments
- Humberto Aguilar Shreveport, LA Named on 26 payments
- Esther Torres San Juan, PR Named on 25 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.